FIP Council Appoints New Scientific Secretary
This article was originally published in Scrip
The International Pharmaceutical Federation Council has appointed Giovanni M. Pauletti scientific secretary of the FIP - effective Oct. 5, 2015. Currently Pauletti is associate professor of biopharmaceutics and pharmacokinetics at the James L. Winkle College of Pharmacy, University of Cincinnati, USA, where he is also the director of its pharmaceutical sciences graduate program.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.